<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00556738</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2007/09</org_study_id>
    <secondary_id>2007-A00666-47</secondary_id>
    <nct_id>NCT00556738</nct_id>
  </id_info>
  <brief_title>Intrapulmonary Percussive Ventilation (IPV) Versus Nasal Continuous Positive Airway Pressure Ventilation (nCPAP) in Transient Respiratory Distress of the Newborn</brief_title>
  <acronym>HFPV</acronym>
  <official_title>Intrapulmonary Percussive Ventilation and Nasal Continuous Positive Airway Pressure Ventilation in Transient Respiratory Distress of the Newborn: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During caesarean section, transient respiratory distress which occurs frequently (3%) with
      possible complications are at present managed by non invasive nasal continuous positive
      airway pressure ventilation (nCPAP) associated with oxygen therapy. Intrapulmonary Percussive
      Ventilation (IPV) is a non-invasive ventilatory mode used in some intensive care units to
      treat some respiratory distress syndrome of the newborn with a good tolerance, but without
      evaluation in prospective studies
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Principal Objective: To show that IPV ventilation can decrease the duration of transient
           respiratory distress as well as the risk of complications.

        -  Secondary Objective: Comparison between the two groups regarding: Length of oxygen
           therapy, complications (pneumothorax, pulmonary infections), need for intensive care
           hospitalization

        -  Study design: Open, prospective randomized trial.

        -  Inclusion criteria: Neonates with gestational age ≥ 35 weeks and weight ≥ 2000g,
           caesarean section, respiratory distress syndrome (modified Silverman score &gt; 5, SpO2 &lt;
           90%), management within 20 minutes after birth.

        -  Exclusion criteria: clinical thoracic retraction, congenital lung malformation, meconium
           aspiration, neonatal infection, other congenital malformations.

        -  Study plan: After the screening evaluation and written consent document, neonates will
           be randomized into two groups: nCPAP ventilation or IPV. During the 6 hours after
           randomization, clinical data will be monitored: cardiac and respiratory frequency (CF
           -RF), saturation (SaO2), oxygenotherapy, Silverman Score. Then, neonates will be
           supervised 3 days after normalization of the respiratory distress.

        -  Number of subjects: 100 (50 in each group)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in time (min) required to normalize the respiratory distress (modified Silverman score = 0, no need for oxygen, RF &lt; 50 bpm and SaO2 &gt; 92%) between the two ventilatory modes</measure>
    <time_frame>Within the first 6 hours after birth</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of pneumothorax, lung infections, transfer to intensive care service, time of oxygenotherapy</measure>
    <time_frame>Within the first 72 hours after birth</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Respiratory Distress Syndrome, Newborn</condition>
  <arm_group>
    <arm_group_label>nHFPV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intrapulmonary Percussive Ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nCPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nasal Continuous Positive Airway Pressure ventilation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nasal Continuous Positive Airway Pressure ventilation</intervention_name>
    <description>Nasal Continuous Positive Airway Pressure ventilation</description>
    <arm_group_label>nCPAP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intrapulmonary Percussive Ventilation</intervention_name>
    <description>Intrapulmonary Percussive Ventilation</description>
    <arm_group_label>nHFPV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Caesarean newborn

          -  Gestational age ≥ 35 weeks

          -  Weight ≥ 2 kg

          -  SaO2 &lt; 90% after 10 min of life

          -  Silverman score ≥ 5

          -  Treated less than 20 min after birth

          -  Social security affiliation (parents)

          -  Informed consent signed (parents)

        Exclusion Criteria:

          -  Thoracic retraction

          -  Congenital intrathoracic malformations

          -  Meconium aspiration

          -  Early neonatal infections with hemodynamic troubles

          -  Severe neonatal asphyxia

          -  Polymalformative syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clothilde Bertrand, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Néonatalogie - Maternité - Hôpital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2007</study_first_submitted>
  <study_first_submitted_qc>November 9, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 12, 2007</study_first_posted>
  <last_update_submitted>May 12, 2010</last_update_submitted>
  <last_update_submitted_qc>May 12, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 13, 2010</last_update_posted>
  <responsible_party>
    <name_title>Jean-Pierre LEROY / Clinical research and Innovation director</name_title>
    <organization>University hospital, Bordeaux</organization>
  </responsible_party>
  <keyword>HFPV</keyword>
  <keyword>neonatal respiratory distress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

